01 1Icrom S.r.l.
02 1MSN Laboratories Private Limited
03 1Micro Labs Limited
04 1UBE Corporation
01 1Bepotastine
02 3Bepotastine Besilate
01 1Germany
02 2India
03 1Italy
NDC Package Code : 40700-0040
Start Marketing Date : 2011-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42571-277
Start Marketing Date : 2013-08-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0088
Start Marketing Date : 2014-02-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42672-0100
Start Marketing Date : 2009-08-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Bepotastine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bepotastine, including repackagers and relabelers. The FDA regulates Bepotastine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bepotastine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bepotastine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bepotastine supplier is an individual or a company that provides Bepotastine active pharmaceutical ingredient (API) or Bepotastine finished formulations upon request. The Bepotastine suppliers may include Bepotastine API manufacturers, exporters, distributors and traders.
click here to find a list of Bepotastine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bepotastine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bepotastine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bepotastine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bepotastine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bepotastine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bepotastine suppliers with NDC on PharmaCompass.
We have 4 companies offering Bepotastine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
